Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A fusion protein that can self-assemble into protein nanoparticles and its application

A fusion protein and nanoparticle technology, applied in the field of fusion proteins, can solve problems such as weak immune response ability, and achieve the effect of treating bacterial infection and significant clinical value

Active Publication Date: 2022-05-03
ACADEMY OF MILITARY MEDICAL SCI
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the polysaccharide conjugate vaccine prepared by the current technology still has weak immune response ability against certain bacteria, and the response level needs to be further improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A fusion protein that can self-assemble into protein nanoparticles and its application
  • A fusion protein that can self-assemble into protein nanoparticles and its application
  • A fusion protein that can self-assemble into protein nanoparticles and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0140] Example 1. Construction and expression of nanoparticle vectors

[0141] 1) Construction of B5Tri fusion protein expression vector

[0142] In this example, a vector expressing B5 protein and Tri sequence fusion protein (B5Tri) is constructed, wherein, B5 protein includes cholera toxin B subunit (CTB), Shiga toxin B subunit (StxB), Escherichia coli heat-labile enterotoxin (LTB), Bacillus subtilisin B subunit (SubB), the Tri sequence is SEQ ID NO.9. The build method is as follows:

[0143]Construction of CTBTri expression vector: According to the amino acid sequence of cholera toxin B subunit (X76390.1) published by GeneBack, its signal peptide (the first 21 amino acids) was replaced with DsbA signal peptide (SEQ ID NO.31), at the C-terminal of CTB The Tri sequence was fused to construct the CTB fusion protein CTBTri. In the CTBTri expression cassette, the expression of CTBTri is initiated by the tac promoter, and the expression cassette is named as tacCTBTri, and its ...

Embodiment 2

[0151] Embodiment 2. Purification and detection of nanoparticles

[0152] Inoculate BL21 / pET28-tacB5Tri in LB medium with a final concentration of 50 μg / mL kanamycin, culture at 37°C, 220 rpm for 10 hours, then transfer to 5L LB medium at 37°C, and culture at 220 rpm When the OD600 was about 0.6, IPTG with a final concentration of 1 mM was added, and the temperature was lowered to 30° C. for 10 h.

[0153] Sample treatment: Take the above-mentioned bacteria induced at 30°C for 10 hours, add 400mL loading buffer (20mM pH7.5 Tris-HCl, 0.2M NaCl, 10mM imidazole), and ultrasonically break the bacteria (sonication for 3s and pause for 5s, and the cumulative ultrasonication time is 30min) , centrifuged at 12000g, and collected the supernatant.

[0154] Sample purification: first wash the column bed with 0.5M NaOH aqueous solution for at least 3 column bed volumes, then equilibrate to neutral pH with deionized water, and then use 0.5M NiSO 4 Equilibrate at least 3 column bed volume...

Embodiment 3

[0156] Example 3. Preparation of Nanoscale Bacterial Polysaccharide Conjugated Vaccines by Biological Method

[0157] 3.1 Construction of B5Tri (B5 respectively CTB, StxB, LTB and SubB) glycosylation expression vector

[0158] 3.1.1 Construction of Neisseria meningitidis glycosyltransferase PglL expression vector: The amino acid sequence of Neisseria meningitidis glycosyltransferase PglL (GeneBank: JN200826.1) is shown in SEQ ID No.19, and its coding sequence As shown in the 180th-1994th nucleotides of SEQID No.20. The 1st-6th nucleotide of SEQ ID No.20 is the XbaI recognition site, and the 105th-2240th nucleotide is the sequence of the PglL expression cassette. In the PglL expression cassette, the expression of PglL is initiated by the tac promoter. This expression cassette was named tacpglL. Wherein, the 105th-133rd nucleotide of SEQ ID No.20 is the sequence of the tac promoter, the 180th-1994th nucleotide is the coding sequence of Neisseria meningitidis glycosyltransferas...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The present invention relates to recombinant fusion protein and polysaccharide conjugated vaccine. More specifically, the present invention relates to a fusion protein comprising a substrate protein of a pentamer and a peptide sequence capable of forming a trimer, an immunogenic composition comprising the fusion protein, the use of the fusion protein in immunization, As well as the polynucleotide sequence encoding the fusion protein, the expression vector comprising the polynucleotide sequence, and the host cell comprising the expression vector.

Description

technical field [0001] The invention relates to a fusion protein that can be self-assembled into protein nanoparticles and its application, belonging to the field of biomedicine. Background technique [0002] Vaccines play an important role in the prevention of pathogenic bacterial infections. The new generation of vaccine products (subunit vaccines) have higher safety due to their single and clear ingredients, but these vaccines often have low immunogenicity, and will be rapidly diluted and degraded by body fluids after injection, so Often some adjuvant and suitable delivery system are required to promote a maximal immune response. In recent years, research has continuously found that the immune effect can be significantly improved by nano-scale vaccines, especially vaccines based on nano-carriers, which have been continuously applied. The most important feature is that they can replace adjuvants and simultaneously stimulate Cellular immunity and humoral immunity, especia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C12N15/62A61K39/385A61K39/095A61P31/04
CPCC07K14/28C07K14/25C07K14/245C07K14/32C07K14/22A61K39/385A61K39/095A61P31/04C07K2319/55C07K2319/91C07K2319/735A61K2039/6037A61K2039/552A61K2039/55555A61K39/00C12N15/62
Inventor 王恒樑潘超朱力吴军黄竞张璐璐孙鹏曾明王斌刘先凯王东澍冯尔玲刘波
Owner ACADEMY OF MILITARY MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com